New pill tested for Tough-to-Control diabetes
NCT ID NCT06393348
Summary
This study tested whether a new oral medication called HRS-7535 could help adults with type 2 diabetes who still had high blood sugar despite taking two common diabetes drugs (metformin and an SGLT2 inhibitor). For 16 weeks, 155 participants received either the new drug or a placebo pill, while researchers measured changes in blood sugar control and weight. The goal was to see if adding HRS-7535 could better manage diabetes in this difficult-to-treat group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Guangdong, Guangzhou, 51020, China
Conditions
Explore the condition pages connected to this study.